ADDITIONAL INFORMATION ON MICHAEL S. WEISS. COPIED FROM A SEC FORM 424A FILING FOR AVAX TECHNOLOGIES ON JULY 9, 1997.
MICHAEL S. WEISS, ESQ., HAS BEEN A DIRECTOR OF THE COMPANY SINCE MARCH 1996 AND SECRETARY OF THE COMPANY SINCE SEPTEMBER 1995. SINCE NOVEMBER 1993, MR. WEISS HAS BEEN VICE PRESIDENT AND THEN SENIOR MANAGING DIRECTOR OF PARAMOUNT CAPITAL, INC., AND SINCE 1995 HE HAS BEEN GENERAL COUNSEL OF PARAMOUNT CAPITAL INVESTMENTS, LLC. FROM 1991 TO 1993, MR. WEISS WAS AN ATTORNEY WITH CRAVATH, SWAINE & MOORE. MR. WEISS IS A DIRECTOR OF XYTRONYX, INC., PALATIN TECHNOLOGIES, INC., AND SECRETARY OF ATLANTIC PHARMACEUTICALS, INC., EACH OF WHICH IS A PUBLICLY TRADED BIOTECHNOLOGY COMPANY. IN ADDITION, MR. WEISS IS A DIRECTOR OF SEVERAL PRIVATELY-HELD BIOTECHNOLOGY COMPANIES. MR. WEISS RECEIVED HIS J.D. FROM COLUMBIA UNIVERSITY SCHOOL OF LAW AND A B.S. IN FINANCE FROM THE STATE UNIVERSITY OF NEW YORK AT ALBANY. |
